Bysanti Tablet
Product Images NDC 43068-702

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Bysanti (NDC 43068-702). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vanda Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Milsaperidone 01)

BYSANTI tablets by Vanda Pharmaceuticals Inc., containing milsaperidone. The white tablet insert is shown on a white-to-gray gradient background. No visible strength or packaging count is indicated in the image.*

FDA Label Image

Chemical Structure (Milsaperidone 02)

Chemical structure diagram of milsaperidone, the active ingredient in BYSANTI tablets. The structure shows various bonded atoms including fluorine (F) and oxygen (O) within aromatic and heterocyclic rings, representing the molecular framework of milsaperidone.*

FDA Label Image

Figure 1 (Milsaperidone 03)

A forest plot chart showing the mean effect and 90% confidence intervals (CI) of CYP2D6 and CYP3A4 inhibitors on the pharmacokinetics of milsaperidone and iloperidone. The x-axis represents change relative to reference, with horizontal lines and points representing Cmax and AUC∞ values for each drug and inhibitor type.*

FDA Label Image

Figure 2 (Milsaperidone 04)

A Kaplan-Meier curve showing the proportion with relapse or impending relapse over days from randomization in a clinical study. The graph compares two groups: placebo (dashed line) and iloperidone (solid line), with iloperidone showing a lower proportion of relapse over time. The x-axis represents days from randomization with corresponding number of subjects at risk below the axis, and the y-axis represents the proportion with relapse or impending relapse.*

FDA Label Image

Figure 3 (Milsaperidone 05)

A line chart comparing the least squares mean change from baseline over 28 days between placebo and iloperidone groups. The x-axis represents time in days, and the y-axis represents the LS mean change. Data points for both groups show a general downward trend, with iloperidone demonstrating a greater reduction compared to placebo.*

FDA Label Image

60 Tablets 1mg Bottle Label (Milsaperidone 06)

Bysanti milsaperidone 1 mg tablets label showing the drug name, strength, dosage form, and package count of 60 tablets. The label includes storage instructions, a barcode, the labeler Vanda Pharmaceuticals Inc., and the National Drug Code (NDC) 43068-701-02. The label states 'Rx Only' indicating prescription status.*

FDA Label Image

60 Tablets 2mg Bottle Label (Milsaperidone 07)

Bysanti 2 mg milsaperidone tablets packaging label showing oral tablet form, an NDC number 43068-702-02, and a quantity of 60 tablets. The label includes storage instructions, the Vanda Pharmaceuticals Inc. logo, and distributor information in Washington, DC. The label states 'Rx Only' indicating prescription use only.*

FDA Label Image

60 Tablets 4mg Bottle Label (Milsaperidone 08)

Bysanti 4 mg milsaperidone tablets label showing the oral tablet product from Vanda Pharmaceuticals Inc. The label indicates a package size of 60 tablets with storage instructions and a barcode. The label includes regulatory and manufacturing details along with dosage strength and the Rx only designation.*

FDA Label Image

60 Tablets 6mg Bottle Label (Milsaperidone 09)

Label for Bysanti 6 mg milsaperidone tablets showing a package of 60 tablets. The label includes storage instructions and a barcode, with Vanda Pharmaceuticals Inc. as the distributor. The product is prescription-only and is for oral administration.*

FDA Label Image

60 Tablets 8mg Bottle Label (Milsaperidone 10)

Bysanti milsaperidone tablets 8 mg oral tablet label. The label shows the product name, strength, dosage form, and quantity of 60 tablets. It includes storage instructions, a barcode, and is distributed by Vanda Pharmaceuticals Inc. in Washington, D.C. The label specifies the product is prescription only.*

FDA Label Image

60 Tablets 10mg Bottle Label (Milsaperidone 11)

Bysanti 10 mg milsaperidone tablets label shows the product name, strength, and dosage form. The label indicates the package contains 60 tablets and is for prescription use only. It is distributed by Vanda Pharmaceuticals Inc. The label includes storage instructions and a barcode along with a QR code and various product identifiers on the side.*

FDA Label Image

60 Tablets 12mg Bottle Label (Milsaperidone 12)

Bysanti 12 mg milsaperidone tablets packaging label showing a 60-tablet count. The label specifies the product as an oral prescription tablet by Vanda Pharmaceuticals Inc., includes storage instructions, barcode, and distribution information. The design features black and blue text on a white background.*

FDA Label Image

Titration Pack A Mockup (Milsaperidone 13)

Bysanti milsaperidone tablets Titration Pack A packaging label showing a blister card containing eight oral tablets in varied strengths: 1 mg, 2 mg, 4 mg, and 6 mg. The label includes dosing instructions for morning and evening administration, sequentially arranged by day, and graphic instructions for opening the blister. Distributed by Vanda Pharmaceuticals Inc.*

FDA Label Image

Titration Pack B Mock-up (Milsaperidone 14)

Bysanti milsaperidone tablets Titration Pack B packaging label, distributed by Vanda Pharmaceuticals Inc. The pack contains twelve tablets of various strengths: six 1 mg, two 2 mg, two 6 mg, and two 8 mg tablets. The label includes detailed dosing instructions illustrated for a multi-day regimen and instructions for opening the blister pack.*

FDA Label Image

Titration Pack C Mock-up (Milsaperidone 15)

Bysanti (milsaperidone) tablets titration pack C packaging label showing an 8-tablet blister pack with dosing instructions for morning and evening administration over 3 days. The pack includes four 1 mg tablets, two 2 mg tablets, and two 6 mg tablets. Labeler is Vanda Pharmaceuticals Inc., with clear dosage and administration guidance.*

FDA Label Image

14 Tablets 1mg Carton Label (Milsaperidone 16)

Bysanti milsaperidone 1 mg tablets packaging label for a prescription drug by Vanda Pharmaceuticals Inc. The label indicates the product contains 14 tablets and is a professional sample not for sale. Storage instructions and distributor information are included, alongside barcodes and lot/expiration placeholder text.*

FDA Label Image

14 Tablets 1mg Bottle Label (Milsaperidone 17)

Bysanti 1 mg milsaperidone tablets packaging label, containing 14 tablets. Label indicates professional sample not for sale, distributed by Vanda Pharmaceuticals Inc. Storage instructions and prescription-only status are also displayed. The label includes NDC 43068-908-14 and spaces for lot and expiration information.*

FDA Label Image

14 Tablets 6mg Carton Label (Milsaperidone 18)

Bysanti 6 mg milsaperidone tablets packaging label for a 14-tablet bottle. The label states the product is a professional sample, not for sale, and for prescription use only. It includes storage instructions and is distributed by Vanda Pharmaceuticals Inc. The NDC code 43068-910-14 is visible on the label.*

FDA Label Image

14 Tablets 6mg Bottle Label (Milsaperidone 19)

Bysanti 6 mg milsaperidone tablets label, a professional sample not for sale. The label shows the product name, strength, dosage form, and count of 14 tablets. It is marked for prescription use only and distributed by Vanda Pharmaceuticals Inc., Washington, D.C., USA. Storage instructions and lot/expiration placeholders are also visible.*

FDA Label Image

14 Tablets 8mg Carton Label (Milsaperidone 20)

Bysanti 8 mg milsaperidone tablets carton label for oral use, containing 14 tablets. The label indicates it is a professional sample not for sale. Distributed by Vanda Pharmaceuticals Inc., Washington, D.C. Storage instructions specify 20°C to 25°C with permitted excursions. The NDC number 43068-911-14 is displayed.*

FDA Label Image

14 Tablets 8mg Bottle Label (Milsaperidone 21)

Label for Bysanti milsaperidone tablets, 8 mg strength, oral tablets. The label indicates a professional sample not for sale, containing 14 tablets. It is distributed by Vanda Pharmaceuticals Inc., Washington, D.C. Storage instructions and packaging details are included along with the NDC number 43068-911-14.*

FDA Label Image

Titration Pack A Professional (Milsaperidone 22)

Bysanti milsaperidone tablets Titration Pack A packaging label by Vanda Pharmaceuticals Inc. It is a professional sample not for sale, containing 8 tablets in various strengths: two 1 mg, two 2 mg, two 4 mg, and two 6 mg tablets. The label includes dosage instructions, lot and expiration placeholders, peel tabs for individual tablets, and methods for opening the blister pack, designed for oral administration.*

FDA Label Image

Titration Pack B Professional (Milsaperidone 23)

The image shows a packaging label for Bysanti milsaperidone tablets titled Titration Pack B. The pack contains 12 tablets in various strengths: six 1 mg, two 2 mg, two 6 mg, and two 8 mg tablets. It includes dosage instructions with labeled blister segments for morning and evening doses over four days. The labeler is Vanda Pharmaceuticals Inc., and the product is marked as a professional sample, not for sale.*

FDA Label Image

Titration Pack C Professional (Milsaperidone 24)

Bysanti milsaperidone tablets Titration Pack C professional sample packaging label. The label shows an 8-tablet blister pack with different strengths for titration: four 1 mg, two 2 mg, and two 6 mg tablets. Includes dosing instructions for morning and evening administration and illustrated opening instructions. Distributed by Vanda Pharmaceuticals Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.